Catalog Number BNI35DFH |
Device Problem
Patient Device Interaction Problem (4001)
|
Patient Problem
Cardiac Tamponade (2226)
|
Event Date 03/15/2024 |
Event Type
Injury
|
Event Description
|
It was reported that a patient underwent a cardiac ablation and the patient experienced cardiac tamponade that required pericardiocentesis.Performed cavotricuspid ishmus (cti) on patient - fairly long ablation time.Pulled all catheters out of the heart.At this point, the intervention/ablation was over.Patient went bradycardic, echo indicated pericardial tamponade.Drained tamponade, patient stabilized.Extended hospital stay.Additional information was received.Tamponade occurred during a cti ablation.Post ablation, the tamponade was discovered.The patient then had a vagal reaction and a tee confirmed pericardial tamponade.Drainage with a syringe was performed.Patient had improved but had to stay to recover/be observed for additional consequences of the tamponade.No service needed to the generator and pump.Physician's opinion on the cause of this adverse event was procedure, possibly in addition to patient condition.No biosense webster, inc.Product malfunction was suspected or observed.
|
|
Manufacturer Narrative
|
Initial reporter phone: (b)(6).If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by biosense webster, inc., or its employees that the report constitutes an admission that the product, biosense webster, inc., or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Manufacturer's reference number: (b)(4).
|
|
Manufacturer Narrative
|
It was reported that a patient underwent a cardiac ablation and the patient experienced cardiac tamponade that required pericardiocentesis.Extended hospital stay.The bwi product analysis lab received the device for evaluation on 03-may-2024.The device evaluation was completed on 14-may-2024.The product was returned to biosense webster (bwi) for evaluation.A visual inspection and revision of all features were performed following bwi procedures.Visual analysis revealed no damage or anomalies on the device.The device features were reviewed, and no issues were observed during the product investigation.A manufacturing record evaluation was performed for the finished device batch number, and no internal actions were identified.No malfunction was observed during the product analysis.The physician's opinion on the cause of this adverse event was the procedure, possibly in addition to patient's condition.The root cause of the adverse event remains unknown.In addition, no device malfunction was reported, there may have been other circumstances or issues that occurred during the use of the device that could not be replicated during the analysis.The instruction for use (ifu) states that careful catheter manipulation must be performed to avoid cardiac damage, perforation, or tamponade.As part of biosense webster¿s quality process, all devices are manufactured, inspected, and released to approved specifications.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's reference number: (b)(4).
|
|
Search Alerts/Recalls
|
|